Effects of neurohypophyseal hormone analogues on blood clotting factor VIII and fibrinolytic activity in sheep

European Journal of Pharmacology

Volumn 323, Issue 2-3, 1997, Pages 205-213

  Neuenschwander, Stefan ^a   Pliška, Vladimir ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Antihemophilic factor; Blood clotting; Dose response analysis; Factor VIII (F VIII); Neurohypophyseal hormone analog; Non monotonic profile; Oxytocin; Plasminogen activator; Time response; Vasopressin

Indexed keywords

ARGIPRESSIN[4 VALINE]; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; NEUROHYPOPHYSIS HORMONE; OXYTOCIN; OXYTOCIN DERIVATIVE; PLASMINOGEN ACTIVATOR; VASOPRESSIN ANTAGONIST; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FIBRINOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; BLOOD COAGULATION; BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIII; FEMALE; FIBRINOLYTIC AGENTS; HEMATOCRIT; HEMOSTATICS; RECEPTORS, VASOPRESSIN; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP; VASOPRESSINS;

EID: 17444436457     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00036-8     Document Type: Article

References (29)

1. Astrup, T. and S. Müllerts, 1952, The fibrin plate method for estimating fibrinolytic activity, Arch. Biochem. Biophys. 40, 346.
2. Cash, J.D., A.R. Lind, G.W. McNicol and D.C. Woodfield, 1969, Fibrinolytic and forearm blood flow responses to intravenous adrenaline in healthy subjects, Life Sci. 8, 207.
3. Cash, J.D., A.M.A. Gader and J. Da Costa, 1974, The release of plasminogen activator and factor VIII by LVP, DDAVP, AT III and OT in man, Br. J. Haematol. 27, 363.
4. Cash, J.D., A.M.A. Gader, J.L. Mulder and J.H. Cort, 1978, Structure-activity relations of the fibrinolytic response to vasopressin in man, Clin. Sci. Mol. Med. 54, 403.
5. Chakrabarti, R. and G.R. Fearnley, 1962, The fibrinolytic potential as a simple measure of spontaneous fibrinolysis, J. Clin. Pathol. 15, 222.
6. Desnoyers, P.C., M. Anstett, J. LaBaume and H. Schmitt, 1975, Effect of α- and β-adrenoceptor stimulating and blocking agents on fibrinolytic activity in rats, in: Progress in Chemical Fibrinolysis and Thrombolysis, eds. J.F. Davidson, M.M. Samama and P.C. Desnoyers (Raven Press, New York, NY) p. 367.
7. Gader, A.M.A., A.R. Clarkson and J.D. Cash, 1973, The plasminogen activator and coagulation factor VIII response to adrenaline, noradrenaline, isoprenaline and salbutamol in man, Thromb. Res. 2, 9.
8. Hampel, F.R., 1986, Robust Statistics (Wiley, New York, NY).
9. 8)-vasopressin and adrenaline in sheep: proposal for an in vivo assay system, Br. J. Pharmacol. 94, 279.
10. Hruby, V.J. and C.W. Smith, 1987, Structure-activity relationships of neurohypophyseal peptides, in: The Peptides: Analysis, Synthesis, Biology, Vol. 8, eds. S. Udenfriend and J. Meienhofer, in: Chemistry, Biology, and Medicine of Neurohypophyseal Hormones and Their Analogs, ed. C.W. Smith (Academic Press, New York, NY) p. 77.
11. Keber, D., M. Stegnar and C. Kluft, 1990, Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion, Thromb. Haemost. 63, 72.
12. Manning, M. and W.H. Sawyer, 1993, Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin, J. Recept. Res. 13, 195.
13. Mannucci, P.M., M. Åberg, I.M. Nilsson and B. Robertson, 1975, Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs, Br. J. Haematol. 30, 81.
14. Mannucci P.M., Z.M. Ruggeri, F.I. Pareti and A. Capitanio, 1977a, 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease, Lancet i, 869.
15. Mannucci P.M., Z.M. Ruggeri, F.I. Pareti and A. Capitanio, 1977b, D.D.A.V.P. in haemophilia, Lancet ii, 1171.
16. Neuenschwander, S. and V. Pliška, 1994, Factor VIII in blood plasma of haemophilic sheep: analysis of clotting time-plasma dilution curves, Haemostasis 24, 27.
17. Neuenschwander, S., E. Lang, J. Heiniger and V. Pliška, 1989, Antihemophilic effect (factor VIII enhancing) of neurohypophyseal hormone agonists and antagonists in sheep, in: Proceedings of the Fourth International Conference on the Neurohypophysis: New Aspects of Morphology, Function and Regulation, eds. N.A. Thorn, H. Vilhardt and M. Treiman (Oxford University Press, Oxford) p. 162.
18. Pliška, V., 1994, Models to explain dose-response relationships that exhibit a downturn phase, Trends Pharmacol. Sci. 15, 178.
19. Pliška, V. and S. Neuenschwander, 1994, Neurohypophyseal hormone analogues and blood coagulation: how successful can a design of 'antihemophilic' peptides be?, in: Peptides: Chemistry, Structure and Biology (Proceedings of the Thirteenth American Peptide Symposium, Edmonton, Alberta, Canada, June 20-25, 1993), ed. R.S. Hodges (ESCOM Science Publishers, Leiden) p. 438.
20. Pliška, V., B. Schwander., W. Allmendinger and A. Müller-Lhotsky, 1982, Erbliche Haemophilie beim Schaf: Untersuchungen an potentiellen Konduktorinnen, Schweiz. Landw. Monatsh. 60, 284.
21. Prowse, C.V., G. Sas, A.M.A. Gader, J.H. Cort and J.D. Cash, 1979, Specificity in the factor VIII response to vasopressin infusion in man, Br. J. Haematol. 41, 437.
22. Römer, D., H.H. Büscher, R.C. Hill, J. Pless, W. Bauer, F. Cardinaux, A. Closse, D. Hauser and R. Hugenin, 1977, A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity, Nature 268, 547.
23. Rousseeuw, P.J., 1984, Least median of squares regression, J. Am. Statist. Assoc. 79, 871.
24. Rousseeuw, P.J. and A.M. Leroy, 1987, Robust Regression and Outlier Detection (Wiley-Interscience, New York, NY).
25. Simpson, D.G. and G.E. Dallal, 1989, BUMP: a FORTRAN program for identifying dose-response curves subject to downturns, Comput. Biomed. Res. 22, 36.
26. Vilhardt, H. and T. Barth, 1991, Structure-activity relationships of vasopressin analogues on release of factor VIII in dogs, J. Recept. Res. 11, 233.
27. Vilhardt, H. and T. Barth, 1992, Factor VIII and tissue plasminogen activator in monkeys after administration of DDAVP analogues, Thromb. Res. 68, 501.
28. Vilhardt, H., T. Barth, J. Falch and I.M. Nilsson, 1987, Plasma concentrations of factor VIII after administration of DDAVP to conscious dogs, Thromb. Res. 47, 585.
29. Vilhardt, H., T. Barth, P. Melin and C.-J. Aurell, 1993, Antidiuretic activity and release of factor VIII by vasopressin analogues, Eur. J. Pharmacol. 232, 223.